These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12023692)

  • 41. Central dopaminergic regulation of aldosterone secretion in sheep.
    Huang BS; Malvin RL; Lee J; Grekin RJ
    Hypertension; 1987 Aug; 10(2):157-63. PubMed ID: 3301664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sympathoinhibitory and depressor responses to long-term infusion of nifedipine in spontaneously hypertensive rats on high-salt diet.
    Huang BS; Murzenok PP; Leenen FH
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):704-10. PubMed ID: 11117369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mineralocorticoid and hypertensive effects of 19-nor-progesterone.
    Hall CE; Gomez-Sanchez CE; Hungerford S; Gomez-Sanchez EP
    Endocrinology; 1981 Oct; 109(4):1168-75. PubMed ID: 7285865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertensive mechanisms associated with centrally administered aldosterone in dogs.
    Kageyama Y; Bravo EL
    Hypertension; 1988 Jun; 11(6 Pt 2):750-3. PubMed ID: 3391682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central infusion of aldosterone increases blood pressure by mechanisms independent of Na retention.
    Peysner K; Henry CA; Malvin RL
    Clin Exp Hypertens A; 1990; 12(3):399-414. PubMed ID: 2192823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central and peripheral effects of the peptide ANF on renal function and blood pressure in hypertensive rats.
    al-Barazanji K; Balment RJ
    J Physiol; 1989 Nov; 418():261-71. PubMed ID: 2533609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of sodium depletion and potassium loading on cortisol induced hypertension in sheep.
    Mills EH; Coghlan JP; Denton DA; Spence CD; Whitworth JA; Scoggins BA
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):298-304. PubMed ID: 3776438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic ouabain infusion does not cause hypertension in sheep.
    Pidgeon GB; Richards AM; Nicholls MG; Charles CJ; Rademaker MT; Lynn KL; Bailey RR; Lewis LK; Yandle TG
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E386-92. PubMed ID: 8638682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent.
    Lohmeier TE; Montani JP; Smith MJ; Rushing EL
    Hypertension; 1989 Mar; 13(3):273-82. PubMed ID: 2921081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Local renal medullary L-NAME infusion enhances the effect of long-term angiotensin II treatment.
    Szentiványi M; Maeda CY; Cowley AW
    Hypertension; 1999 Jan; 33(1 Pt 2):440-5. PubMed ID: 9931144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 19-Hydroxyandrostenedione amplifies the hypertensive action of mineralocorticoids in rats.
    Sekihara H; Yazaki Y; Kojima T
    J Endocrinol; 1993 Jul; 138(1):31-40. PubMed ID: 7852890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically.
    Hildebrandt DA; Mizelle HL; Brands MW; Gaillard CA; Smith MJ; Hall JE
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R585-92. PubMed ID: 2144407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal, hormonal, and cardiovascular responses to chronic angiotensin I infusion in the ovine fetus.
    Moritz KM; Tangalakis K; Wintour EM
    Am J Physiol; 1997 Jun; 272(6 Pt 2):R1912-7. PubMed ID: 9227607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Body fluid and electrolyte composition in arterial hypertension. II. Studies in mineralocorticoid hypertension.
    CHOBANIAN AV; BURROWS BA; HOLLANDER W
    J Clin Invest; 1961 Feb; 40(2):416-22. PubMed ID: 13693217
    [No Abstract]   [Full Text] [Related]  

  • 55. Regional hemodynamic and endocrine effects of aldosterone and cortisol in conscious sheep. Comparison with the effects of corticotropin.
    May CN; Bednarik JA
    Hypertension; 1995 Aug; 26(2):294-300. PubMed ID: 7635538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose-response studies of intracerebroventricular infusion of aldosterone in sensitized and non-sensitized rats.
    Gomez Sanchez EP
    J Hypertens; 1988 Jun; 6(6):437-42. PubMed ID: 3411122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
    Weisinger RS; Blair-West JR; Burns P; Denton DA; Purcell B; Vale W; Rivier J; Weisinger HS; May CN
    Endocrinology; 2004 Dec; 145(12):5598-604. PubMed ID: 15319360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Hypertension; 2001 Oct; 38(4):902-6. PubMed ID: 11641306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of nitric oxide in the development of corticotropin-induced hypertension in sheep.
    Tresham JJ; May CN
    Clin Exp Pharmacol Physiol; 1998 Feb; 25(2):128-30. PubMed ID: 9493501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baroreceptor-independent renal nerve inhibition by intracerebroventricular angiotensin II in conscious sheep.
    May CN; McAllen RM
    Am J Physiol; 1997 Aug; 273(2 Pt 2):R560-7. PubMed ID: 9277539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.